{"entity":{"type":"insider","cik":"0001408502","url":"/insider/0001408502","json_url":"/insider/0001408502.json","name":"Hahn Mark W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":49,"n_filings":31,"first":"2018-12-21","last":"2025-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Hahn Mark W","source":"filing","n_filings":31,"first_seen":"2018-12-21","last_seen":"2025-08-05"}],"transactions":[{"id":4725525,"accession":"0001104659-25-074398","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-074398","line_url":"/filing/0001104659-25-074398#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":208912.0,"shares_display":"208,912","price_per_share":13.1437,"price_display":"13.14","price_state":"stated","total_value":2745876.6544,"total_display":"2,745,876.65","total_whole":"2,745,877","shares_owned_after":12464968.0,"shares_owned_after_display":"12,464,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-01","filed_date":"2025-08-05","scope":"insider"},{"id":4875570,"accession":"0001104659-25-059403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-059403","line_url":"/filing/0001104659-25-059403#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":11.4009,"price_display":"11.40","price_state":"stated","total_value":4560360.0,"total_display":"4,560,360.00","total_whole":"4,560,360","shares_owned_after":12278992.0,"shares_owned_after_display":"12,278,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-11","filed_date":"2025-06-13","scope":"insider"},{"id":4592796,"accession":"0001104659-25-054266","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-054266","line_url":"/filing/0001104659-25-054266#line-3","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":204864.0,"shares_display":"204,864","price_per_share":9.3314,"price_display":"9.33","price_state":"stated","total_value":1911667.9296,"total_display":"1,911,667.93","total_whole":"1,911,668","shares_owned_after":12678992.0,"shares_owned_after_display":"12,678,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-29","filed_date":"2025-05-29","scope":"insider"},{"id":4592793,"accession":"0001104659-25-054266","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-054266","line_url":"/filing/0001104659-25-054266#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":162704.0,"shares_display":"162,704","price_per_share":9.3009,"price_display":"9.30","price_state":"stated","total_value":1513293.6336,"total_display":"1,513,293.63","total_whole":"1,513,294","shares_owned_after":12883856.0,"shares_owned_after_display":"12,883,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-28","filed_date":"2025-05-29","scope":"insider"},{"id":4592790,"accession":"0001104659-25-054266","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-054266","line_url":"/filing/0001104659-25-054266#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32432.0,"shares_display":"32,432","price_per_share":9.5271,"price_display":"9.53","price_state":"stated","total_value":308982.9072,"total_display":"308,982.91","total_whole":"308,983","shares_owned_after":13046560.0,"shares_owned_after_display":"13,046,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-27","filed_date":"2025-05-29","scope":"insider"},{"id":4592624,"accession":"0001104659-25-044536","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-044536","line_url":"/filing/0001104659-25-044536#line-4","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":9.0943,"price_display":"9.09","price_state":"stated","total_value":3637720.0,"total_display":"3,637,720.00","total_whole":"3,637,720","shares_owned_after":13078992.0,"shares_owned_after_display":"13,078,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-05","scope":"insider"},{"id":4592622,"accession":"0001104659-25-044536","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-044536","line_url":"/filing/0001104659-25-044536","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":187008.0,"shares_display":"187,008","price_per_share":8.9502,"price_display":"8.95","price_state":"stated","total_value":1673759.0016,"total_display":"1,673,759.00","total_whole":"1,673,759","shares_owned_after":13357728.0,"shares_owned_after_display":"13,357,728","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-05","scope":"insider","n_lines":2},{"id":5043436,"accession":"0001104659-25-043645","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-043645","line_url":"/filing/0001104659-25-043645#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90360.0,"shares_display":"90,360","price_per_share":8.98,"price_display":"8.98","price_state":"stated","total_value":811432.8,"total_display":"811,432.80","total_whole":"811,433","shares_owned_after":13466000.0,"shares_owned_after_display":"13,466,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-29","filed_date":"2025-05-01","scope":"insider"},{"id":2035581,"accession":"0001104659-24-126371","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-126371","line_url":"/filing/0001104659-24-126371#line-3","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":183728.0,"shares_display":"183,728","price_per_share":5.0091,"price_display":"5.01","price_state":"stated","total_value":920311.9248,"total_display":"920,311.92","total_whole":"920,312","shares_owned_after":13293736.0,"shares_owned_after_display":"13,293,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-06","filed_date":"2024-12-06","scope":"insider"},{"id":2035580,"accession":"0001104659-24-126371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-126371","line_url":"/filing/0001104659-24-126371#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":640048.0,"shares_display":"640,048","price_per_share":5.0061,"price_display":"5.01","price_state":"stated","total_value":3204144.2928,"total_display":"3,204,144.29","total_whole":"3,204,144","shares_owned_after":13477464.0,"shares_owned_after_display":"13,477,464","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-05","filed_date":"2024-12-06","scope":"insider"},{"id":2035579,"accession":"0001104659-24-126371","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-126371","line_url":"/filing/0001104659-24-126371#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58184.0,"shares_display":"58,184","price_per_share":5.0013,"price_display":"5.00","price_state":"stated","total_value":290995.6392,"total_display":"290,995.64","total_whole":"290,996","shares_owned_after":14117512.0,"shares_owned_after_display":"14,117,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-06","scope":"insider"},{"id":2538546,"accession":"0001104659-24-124757","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-124757","line_url":"/filing/0001104659-24-124757#line-3","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","total_whole":"8,000","shares_owned_after":14175696.0,"shares_owned_after_display":"14,175,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-02","scope":"insider"},{"id":2538544,"accession":"0001104659-24-124757","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-124757","line_url":"/filing/0001104659-24-124757#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98704.0,"shares_display":"98,704","price_per_share":5.0063,"price_display":"5.01","price_state":"stated","total_value":494141.8352,"total_display":"494,141.84","total_whole":"494,142","shares_owned_after":14177296.0,"shares_owned_after_display":"14,177,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-29","filed_date":"2024-12-02","scope":"insider"},{"id":2538541,"accession":"0001104659-24-124757","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-124757","line_url":"/filing/0001104659-24-124757#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12936.0,"shares_display":"12,936","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":64680.0,"total_display":"64,680.00","total_whole":"64,680","shares_owned_after":14276000.0,"shares_owned_after_display":"14,276,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-27","filed_date":"2024-12-02","scope":"insider"},{"id":2171473,"accession":"0001104659-24-123211","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-123211","line_url":"/filing/0001104659-24-123211#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","total_whole":"4,000","shares_owned_after":14288936.0,"shares_owned_after_display":"14,288,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-26","filed_date":"2024-11-26","scope":"insider"},{"id":2171468,"accession":"0001104659-24-123211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-123211","line_url":"/filing/0001104659-24-123211#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","total_whole":"8,000","shares_owned_after":14289736.0,"shares_owned_after_display":"14,289,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-26","scope":"insider"},{"id":2907873,"accession":"0001104659-24-117791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-117791","line_url":"/filing/0001104659-24-117791#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":14291336.0,"shares_owned_after_display":"14,291,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":2315280,"accession":"0001104659-24-114409","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-114409","line_url":"/filing/0001104659-24-114409#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80784.0,"shares_display":"80,784","price_per_share":4.3876,"price_display":"4.39","price_state":"stated","total_value":354447.8784,"total_display":"354,447.88","total_whole":"354,448","shares_owned_after":14293736.0,"shares_owned_after_display":"14,293,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-04","filed_date":"2024-11-05","scope":"insider"},{"id":2315275,"accession":"0001104659-24-114409","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-114409","line_url":"/filing/0001104659-24-114409#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48888.0,"shares_display":"48,888","price_per_share":4.3761,"price_display":"4.38","price_state":"stated","total_value":213938.7768,"total_display":"213,938.78","total_whole":"213,939","shares_owned_after":14374520.0,"shares_owned_after_display":"14,374,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-05","scope":"insider"},{"id":2876057,"accession":"0001104659-24-111567","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-111567","line_url":"/filing/0001104659-24-111567#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":4.375,"price_display":"4.38","price_state":"stated","total_value":14000.0,"total_display":"14,000.00","total_whole":"14,000","shares_owned_after":13669360.0,"shares_owned_after_display":"13,669,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-25","filed_date":"2024-10-25","scope":"insider"},{"id":2876052,"accession":"0001104659-24-111567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-111567","line_url":"/filing/0001104659-24-111567#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":141360.0,"shares_display":"141,360","price_per_share":4.3772,"price_display":"4.38","price_state":"stated","total_value":618760.992,"total_display":"618,760.99","total_whole":"618,761","shares_owned_after":13672560.0,"shares_owned_after_display":"13,672,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-24","filed_date":"2024-10-25","scope":"insider"},{"id":2147146,"accession":"0001104659-24-110658","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-110658","line_url":"/filing/0001104659-24-110658#line-3","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":159344.0,"shares_display":"159,344","price_per_share":4.3849,"price_display":"4.38","price_state":"stated","total_value":698707.5056,"total_display":"698,707.51","total_whole":"698,708","shares_owned_after":13813920.0,"shares_owned_after_display":"13,813,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-22","filed_date":"2024-10-22","scope":"insider"},{"id":2147142,"accession":"0001104659-24-110658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-110658","line_url":"/filing/0001104659-24-110658#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":116696.0,"shares_display":"116,696","price_per_share":4.3796,"price_display":"4.38","price_state":"stated","total_value":511081.8016,"total_display":"511,081.80","total_whole":"511,082","shares_owned_after":13973264.0,"shares_owned_after_display":"13,973,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-21","filed_date":"2024-10-22","scope":"insider"},{"id":2147138,"accession":"0001104659-24-110658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-110658","line_url":"/filing/0001104659-24-110658#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":249728.0,"shares_display":"249,728","price_per_share":4.3807,"price_display":"4.38","price_state":"stated","total_value":1093983.4496,"total_display":"1,093,983.45","total_whole":"1,093,983","shares_owned_after":14089960.0,"shares_owned_after_display":"14,089,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-18","filed_date":"2024-10-22","scope":"insider"},{"id":2600331,"accession":"0001104659-24-099790","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-099790","line_url":"/filing/0001104659-24-099790#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":3.7568,"price_display":"3.76","price_state":"stated","total_value":2254080.0,"total_display":"2,254,080.00","total_whole":"2,254,080","shares_owned_after":14339688.0,"shares_owned_after_display":"14,339,688","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-11","filed_date":"2024-09-13","scope":"insider"},{"id":2184458,"accession":"0001104659-24-089639","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-089639","line_url":"/filing/0001104659-24-089639","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":398400.0,"shares_display":"398,400","price_per_share":3.20165762248996,"price_display":"3.20","price_state":"stated","total_value":1275540.3968,"total_display":"1,275,540.40","total_whole":"1,275,540","shares_owned_after":14943424.0,"shares_owned_after_display":"14,943,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-14","scope":"insider","n_lines":2},{"id":2184454,"accession":"0001104659-24-089639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-089639","line_url":"/filing/0001104659-24-089639#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":3.13,"price_display":"3.13","price_state":"stated","total_value":5008.0,"total_display":"5,008.00","total_whole":"5,008","shares_owned_after":15338088.0,"shares_owned_after_display":"15,338,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-14","scope":"insider"},{"id":8256882,"accession":"0001104659-23-088491","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-088491","line_url":"/filing/0001104659-23-088491#line-3","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8616.0,"shares_display":"8,616","price_per_share":2.4679,"price_display":"2.47","price_state":"stated","total_value":21263.4264,"total_display":"21,263.43","total_whole":"21,263","shares_owned_after":15521248.0,"shares_owned_after_display":"15,521,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-07","scope":"insider"},{"id":8256879,"accession":"0001104659-23-088491","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-088491","line_url":"/filing/0001104659-23-088491#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":2.4992,"price_display":"2.50","price_state":"stated","total_value":374880.0,"total_display":"374,880.00","total_whole":"374,880","shares_owned_after":15529864.0,"shares_owned_after_display":"15,529,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-04","filed_date":"2023-08-07","scope":"insider"},{"id":8256875,"accession":"0001104659-23-088491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-088491","line_url":"/filing/0001104659-23-088491#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":117272.0,"shares_display":"117,272","price_per_share":2.539,"price_display":"2.54","price_state":"stated","total_value":297753.608,"total_display":"297,753.61","total_whole":"297,754","shares_owned_after":15679864.0,"shares_owned_after_display":"15,679,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-03","filed_date":"2023-08-07","scope":"insider"},{"id":8052678,"accession":"0001104659-23-087445","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-087445","line_url":"/filing/0001104659-23-087445#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73704.0,"shares_display":"73,704","price_per_share":2.593,"price_display":"2.59","price_state":"stated","total_value":191114.472,"total_display":"191,114.47","total_whole":"191,114","shares_owned_after":15797136.0,"shares_owned_after_display":"15,797,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-02","filed_date":"2023-08-03","scope":"insider"},{"id":8052675,"accession":"0001104659-23-087445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-087445","line_url":"/filing/0001104659-23-087445#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105944.0,"shares_display":"105,944","price_per_share":2.679,"price_display":"2.68","price_state":"stated","total_value":283823.976,"total_display":"283,823.98","total_whole":"283,824","shares_owned_after":15870840.0,"shares_owned_after_display":"15,870,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider"},{"id":7924897,"accession":"0001104659-23-055647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-055647","line_url":"/filing/0001104659-23-055647#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":455528.0,"shares_display":"455,528","price_per_share":2.5759,"price_display":"2.58","price_state":"stated","total_value":1173394.5752,"total_display":"1,173,394.58","total_whole":"1,173,395","shares_owned_after":15976784.0,"shares_owned_after_display":"15,976,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-03","scope":"insider"},{"id":8356985,"accession":"0001104659-23-010735","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-010735","line_url":"/filing/0001104659-23-010735#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":413168.0,"shares_display":"413,168","price_per_share":2.5572,"price_display":"2.56","price_state":"stated","total_value":1056553.2096,"total_display":"1,056,553.21","total_whole":"1,056,553","shares_owned_after":16432312.0,"shares_owned_after_display":"16,432,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-03","scope":"insider"},{"id":6771141,"accession":"0001104659-22-129083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-129083","line_url":"/filing/0001104659-22-129083#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":2.1151,"price_display":"2.12","price_state":"stated","total_value":1269060.0,"total_display":"1,269,060.00","total_whole":"1,269,060","shares_owned_after":16845480.0,"shares_owned_after_display":"16,845,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"},{"id":6702292,"accession":"0001104659-22-114412","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-114412","line_url":"/filing/0001104659-22-114412#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13160.0,"shares_display":"13,160","price_per_share":1.6726,"price_display":"1.67","price_state":"stated","total_value":22011.416,"total_display":"22,011.42","total_whole":"22,011","shares_owned_after":17445480.0,"shares_owned_after_display":"17,445,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6990934,"accession":"0001104659-22-089565","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-089565","line_url":"/filing/0001104659-22-089565#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":1050000.0,"total_display":"1,050,000.00","total_whole":"1,050,000","shares_owned_after":14313496.0,"shares_owned_after_display":"14,313,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-09","filed_date":"2022-08-11","scope":"insider"},{"id":6680623,"accession":"0001104659-22-085627","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-085627","line_url":"/filing/0001104659-22-085627#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13168.0,"shares_display":"13,168","price_per_share":0.6998,"price_display":"0.70","price_state":"stated","total_value":9214.9664,"total_display":"9,214.97","total_whole":"9,215","shares_owned_after":14913496.0,"shares_owned_after_display":"14,913,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"},{"id":6883092,"accession":"0001104659-22-056606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-056606","line_url":"/filing/0001104659-22-056606#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12512.0,"shares_display":"12,512","price_per_share":0.4956,"price_display":"0.50","price_state":"stated","total_value":6200.9472,"total_display":"6,200.95","total_whole":"6,201","shares_owned_after":15381520.0,"shares_owned_after_display":"15,381,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-03","filed_date":"2022-05-05","scope":"insider"},{"id":6568870,"accession":"0001104659-22-011438","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-011438","line_url":"/filing/0001104659-22-011438#line-3","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10416.0,"shares_display":"10,416","price_per_share":0.7562,"price_display":"0.76","price_state":"stated","total_value":7876.5792,"total_display":"7,876.58","total_whole":"7,877","shares_owned_after":15826160.0,"shares_owned_after_display":"15,826,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-03","scope":"insider"},{"id":4673810,"accession":"0001104659-21-133855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-133855","line_url":"/filing/0001104659-21-133855#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10416.0,"shares_display":"10,416","price_per_share":0.6453,"price_display":"0.65","price_state":"stated","total_value":6721.4448,"total_display":"6,721.44","total_whole":"6,721","shares_owned_after":15991120.0,"shares_owned_after_display":"15,991,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-03","scope":"insider"},{"id":4168166,"accession":"0001104659-21-099691","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-099691","line_url":"/filing/0001104659-21-099691#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10416.0,"shares_display":"10,416","price_per_share":0.767,"price_display":"0.77","price_state":"stated","total_value":7989.072,"total_display":"7,989.07","total_whole":"7,989","shares_owned_after":16456384.0,"shares_owned_after_display":"16,456,384","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-03","scope":"insider"},{"id":5050981,"accession":"0001104659-21-061706","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-061706","line_url":"/filing/0001104659-21-061706#line-2","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10416.0,"shares_display":"10,416","price_per_share":0.8731,"price_display":"0.87","price_state":"stated","total_value":9094.2096,"total_display":"9,094.21","total_whole":"9,094","shares_owned_after":16921640.0,"shares_owned_after_display":"16,921,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-05","scope":"insider"},{"id":4583908,"accession":"0001104659-21-031704","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-031704","line_url":"/filing/0001104659-21-031704#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Verona Pharma plc","issuer_ticker":"VRNA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26728.0,"shares_display":"26,728","price_per_share":1.1438,"price_display":"1.14","price_state":"stated","total_value":30571.4864,"total_display":"30,571.49","total_whole":"30,571","shares_owned_after":19054504.0,"shares_owned_after_display":"19,054,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":8661004,"accession":"0001562180-19-005057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-19-005057","line_url":"/filing/0001562180-19-005057#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":775.0,"shares_display":"775","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":21700.0,"total_display":"21,700.00","total_whole":"21,700","shares_owned_after":9024.0,"shares_owned_after_display":"9,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-30","filed_date":"2019-10-02","scope":"insider"},{"id":8515213,"accession":"0001209191-19-040381","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-040381","line_url":"/filing/0001209191-19-040381#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1545.0,"shares_display":"1,545","price_per_share":14.17,"price_display":"14.17","price_state":"stated","total_value":21892.65,"total_display":"21,892.65","total_whole":"21,893","shares_owned_after":9799.0,"shares_owned_after_display":"9,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-02","scope":"insider"},{"id":6457119,"accession":"0001209191-18-063953","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-063953","line_url":"/filing/0001209191-18-063953#line-1","is_derivative":false,"issuer_cik":"0001408502","issuer_name":"Dova Pharmaceuticals Inc.","issuer_ticker":"DOVA","issuer_name_source":null,"issuer_url":"/issuer/0001408502","owner_cik":"0001408502","owner_name":"Hahn Mark W","owner_display_name":"Hahn Mark W","owner_url":"/insider/0001408502","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":6.28,"price_display":"6.28","price_state":"stated","total_value":15700.0,"total_display":"15,700.00","total_whole":"15,700","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-19","filed_date":"2018-12-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":49,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":48,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":49},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001657312","name":"Verona Pharma plc","url":"/issuer/0001657312","role":"Officer (Chief Financial Officer)","n_filings":28,"first_seen":"2021-03-03","last_seen":"2025-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001685071","name":"Dova Pharmaceuticals Inc.","url":"/issuer/0001685071","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2018-12-21","last_seen":"2019-10-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001408502","retrieved_at":"2026-08-26T07:08:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}